Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study

Documenti analoghi

• Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
  di: Mizokami, Yuji, et al.
  Pubblicazione: (2018)
• Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
  di: Sugano, Kentaro, et al.
  Pubblicazione: (2011)
• Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
  di: Murakami, Kazunari, et al.
  Pubblicazione: (2016)
• Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
  di: Ashida, Kiyoshi, et al.
  Pubblicazione: (2018)
• Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
  di: Kinoshita, Yoshikazu, et al.
  Pubblicazione: (2016)